33 results
8-K
EX-99.5
KA
Kineta Inc
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
produce hazardous waste. Kineta generally contracts with third parties for the disposal of these materials and wastes. Kineta cannot eliminate … potential liabilities. Kineta does not carry specific biological or hazardous waste insurance coverage, and Kineta’s property, casualty and general
425
hvfix60w
6 Jun 22
Business combination disclosure
4:05pm
8-K
EX-2.6
qo4p24 g65ns69u2n
6 Jun 22
Yumanity Therapeutics Announces Definitive Agreements for Two Strategic Transactions
4:02pm
8-K
EX-2.2
qwbf8ueyq4l7b fd
6 Jun 22
Yumanity Therapeutics Announces Definitive Agreements for Two Strategic Transactions
4:02pm
8-K
EX-10.1
nddb57uft083t7r554s
4 Mar 22
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-10.1
izt14
15 Dec 20
Yumanity Therapeutics to Raise $33.6 Million PIPE Contingent on Completion of Reverse Merger with Proteostasis
7:34am
425
EX-10.1
zsmxbyp
15 Dec 20
Business combination disclosure
7:32am
S-4
EX-10.18
jijmx1ql4w03umungul1
23 Sep 20
Registration of securities issued in business combination transactions
4:50pm
8-K
EX-2.1
qn2hs6kuwc9ql
24 Aug 20
Yumanity Therapeutics and Proteostasis Therapeutics Announce
5:31pm
425
EX-2.1
8nkbipmcg 41d3
24 Aug 20
Business combination disclosure
5:28pm